Tarun Handa

Employment

• National Dope Testing Laboratory Scientist D
  2022 - Present
• Fresenius-kabi oncology ltd. Manger
  2017 - 2022
• BIOCON-BMS Research Centre Research Investigator
  2014 - 2017
• Sentiss Pharma (Erstwhile Promed Research Centre) Senior Research Scientist
  2006 - 2009

Education

• National Institute of Pharmaceutical Education and Research PhD
  2009 - 2014
• National Institute of Pharmaceutical Education and Research MS(Pharm)
  2004 - 2006
• Delhi Pharmaceutical Science and Research University B. Pharm.
  2000 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Development and Validation of a Confirmatory Method for 4‐Chlorophenoxyacetic Acid and for Monitoring the Stability of Meclofenoxate in Urine Using Liquid Chromatography‐Tandem Mass Spectrometry
  SEPARATION SCIENCE PLUS 2026 DOI: 10.1002/sscp.70206
  +Save
• Molecular insight into atypical instability behavior of fixed-dose combination containing amlodipine besylate and losartan potassium
  Journal of Pharmaceutical and Biomedical Analysis 2017 DOI: 10.1016/j.jpba.2016.12.035
  +Save
• Study of the forced degradation behavior of prasugrel hydrochloride by Liquid Chromatography with Mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products
  Journal of Separation Science 2015 DOI: 10.1002/jssc.201500442
  +Save
• Explanation through density functional theory of the unanticipated loss of CO2 and differences in mass fragmentation profiles of ritonavir and its rCYP3A4‐mediated metabolites
  Journal of Mass Spectrometry 2014 DOI: 10.1002/jms.3359
  +Save
• Characterization of a new degradation product of nifedipine formed on catalysis by atenolol: A typical case of alteration of degradation pathway of one drug by another
  2014 DOI: 10.1016/j.jpba.2013.10.024
  +Save
• Critical practical aspects in the application of liquid chromatography–mass spectrometric studies for the characterization of impurities and degradation products
  2013 DOI: 10.1016/j.jpba.2013.04.027
  +Save
• A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products
  2012 DOI: 10.1016/j.jpba.2012.03.044
  +Save
• ICH guidance in practice: Degradation behaviour of oseltamivir phosphate under stress conditions
  2012 DOI: 10.1016/j.jpba.2012.01.001
  +Save
• Stress degradation studies on lornoxicam using LC, LC–MS/TOF and LC–MSn
  2011 DOI: 10.1016/j.jpba.2011.06.012
  +Save
• Successful characterization of degradation products of drugs using LC-MS tools: Application to piroxicam and meloxicam
  2011 DOI: 10.1039/c1ay05493g
  +Save